SCHEMBL7342186

SCHEMBL7342186

O=c1[nH]c2ccc(Cl)cc2c(=O)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.54
KDM4E B2RXH2 2/20 0.54
CSF1R P07333 2/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
ROCK2 O75116 1/20 0.54
MAP4K4 O95819 1/20 0.54
LCK P06239 1/20 0.54
PIM1 P11309 1/20 0.54
RPS6KB1 P23443 1/20 0.54
CDK2 P24941 1/20 0.54
MAPK1 P28482 1/20 0.54
EPHA2 P29317 1/20 0.54
FLT3 P36888 1/20 0.54
FRK P42685 1/20 0.54
CLK2 P49760 1/20 0.54
GSK3A P49840 1/20 0.54
GSK3B P49841 1/20 0.54
LIMK1 P53667 1/20 0.54
STK3 Q13188 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8819543 0.98 PARP1 (0.53) PARP1KDM4ECSF1RCA1CA2
SCHEMBL29204435 0.89 PARP1 (0.64) PARP1KDM4ECSF1RROCK2MAP4K4
SCHEMBL7334274 0.88 PARP1 (0.57) PARP1KDM4ECSF1RROCK2MAP4K4
SCHEMBL13833009 0.86 KDM4E (0.67) KDM4ECA1CA2CDK2CAMK2B
SCHEMBL31490922 0.83 LMNA (0.60) PARP1KDM4ECA1CA2MEN1
SCHEMBL14598929 0.83 KDM4E (0.62) KDM4ECA1CA2CDK2CAMK2B
SCHEMBL20227580 0.82 PARP1 (0.67) PARP1KDM4ECSF1RROCK2MAP4K4
SCHEMBL13377739 0.81 MEN1 (0.50) PARP1KDM4ECSF1RCA1CA2
SCHEMBL14355035 0.81 PARP1 (0.62) PARP1KDM4ECSF1RROCK2MAP4K4
SCHEMBL27918352 0.81 PARP1 (0.77) PARP1KDM4ECSF1RROCK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5246996-A None JP disclosed
EP-0640592-B1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID CO (US) 1998-12-30 EP disclosed
WO-1997047624-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-18 WO disclosed
EP-0544168-B1 Use of aminoalkyl substituted 5,6-dihydro-dibenzo(b,e)azepin-6,11-dion-11-oximes as antiviral agents BAYER AG (DE) 1997-09-03 EP disclosed
WO-1996022282-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 WO disclosed
US-5416209-A REVERSE TRANSCRIPTASE INHIBITORS; ANTIRETROVIRAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1995-05-16 US disclosed
EP-0640592-A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1995-03-01 EP disclosed
US-5385899-A Antiretroviral agents BAYER AKTIENGESELLSCHAFT (DE) 1995-01-31 US disclosed
EP-0544171-B1 Use of 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes for the preparation of antiretroviral agents. BAYER AG (DE) 1994-11-17 EP disclosed
JP-H05246996-A 5,6-DIHYDRO-BENZ(B,E)AZEPINE-6,11-DIONE-11-OXIMES BAYER AG 1993-09-24 JP disclosed
EP-0544168-A1 Aminoalkyl substituted 5,6-dihydro-dibenzo(b,e)azepin-6,11-dion-11-oximes BAYER AG (DE) 1993-06-02 EP disclosed
EP-0544171-A1 Use of 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes for the preparation of antiretroviral agents. BAYER AG (DE) 1993-06-02 EP disclosed